ClinicalTrials.govpublic full text
Effect on Beta Cell Function and Glycaemic Control After Insulin and Exenatide Sequential Therapy
type 2 diabetes, the newly onset type 2 diabetes, short-term insulin treatment, exenatide sequential therapy, beta cell function, glycaemic remission, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 840428
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.